GSI 7916 (Epclusa sofosbuvir 400 mg / velpatasvir 100 mg)

Generic Name: sofosbuvir/velpatasvir

Pill imprint GSI 7916 has been identified as Epclusa sofosbuvir 400 mg / velpatasvir 100 mg.

Epclusa is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. Epclusa sofosbuvir 400 mg / velpatasvir 100 mg is classified as a Schedule U controlled substance under the Controlled Substance Act (CSA).

Epclusa

Generic Name:

sofosbuvir/velpatasvir

Imprint:

GSI 7916

Strength:

sofosbuvir 400 mg / velpatasvir 100 mg

Color:

Pink

Shape:

Four-sided

Availability:

Prescription only

Drug Class:

Antiviral combinations

CSA Schedule:

U - Unknown

Manufacturer:

Gilead Sciences, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.